Skip to content

Intervention strategy of Traditional Chinese Medicine for prediabetes(the syndrome of spleen-deficiency phlegm-dampness) based on the reversal of blood glucose and the improvement of fatigue

Intervention strategy of Traditional Chinese Medicine for prediabetes(the syndrome of spleen-deficiency phlegm-dampness) based on the reversal of blood glucose and the improvement of fatigue

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022736
Enrollment
Unknown
Registered
2019-04-23
Start date
2019-05-15
Completion date
Unknown
Last updated
2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prediabetes

Interventions

Sponsors

Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients who meet the diagnostic criteria for the prediabetes with the syndrome of spleen-deficiency phlegm-dampness; (2) Patients with moderate or severe fatigue were included evaluated by the self-rating scale; (3) Aged 30 to 75 years old; (4) No participating in clinical studies of other interventions within 2 weeks before inclusion; (5) Participating in and signing the informed consent voluntarily.

Exclusion criteria

Exclusion criteria: (1) The history of diabetes (except gestational diabetes); (2) Recent cardiovascular events, mental disease, and severe hepatic and renal insufficiency; (3) Hyperthyroidism and other endocrine diseases; (4) Taking glucocorticoid, ßreceptor blockers, thiazide diuretics, niacin and other drugs; (5) Pregnant and lactating women; (6) Participanting in clinical trials of other drugs recently.

Design outcomes

Primary

MeasureTime frame
the score of FS-14 scale;the rate of glycemic reversion;

Secondary

MeasureTime frame
Laboratory index;Safety index;

Countries

China

Contacts

Public ContactLi-Ping Guo

Tianjin University of Traditional Chinese Medicine

lpgtjn@163.com+86 13821806546

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026